{"id":"W2127159621","doi":"10.1158/1078-0432.ccr-08-0351","title":"Polymorphisms and Clinical Outcome in Recurrent Ovarian Cancer Treated with Cyclophosphamide and Bevacizumab","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":184,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Genotype; Bevacizumab; Ovarian cancer; Exact test; Gastroenterology; Internal medicine; Cyclophosphamide; Allele; Progression-free survival; Medicine; Biology; Oncology; Cancer; Chemotherapy; Gene; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003045576,0.0002103785,0.000873886,0.0001747037,0.0002105266,0.00002481739,0.0001221213,0.0002839484,0.000346745],"category_scores_gemma":[0.0008611758,0.0001492943,0.0001126677,0.0005633175,0.001093559,0.00006790518,0.0001555,0.002228498,0.000007719181],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00021584,"about_ca_system_score_gemma":0.0006204513,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005852798,"about_ca_topic_score_gemma":0.001282181,"domain_scores_codex":[0.9964874,0.0005160174,0.001071128,0.0007018148,0.0006257964,0.0005978837],"domain_scores_gemma":[0.9973967,0.001270476,0.000106112,0.000344215,0.0002513017,0.0006312106],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003003196,0.0003789371,0.9357046,0.00006983317,0.00008454851,0.0002541831,0.0001290191,8.431096e-7,0.00006712712,0.00001514195,0.0006764839,0.05961606],"study_design_scores_gemma":[0.008346587,0.001612529,0.9848505,0.000450976,0.00006151394,0.00006937431,0.00007679883,0.0001710433,0.0002676038,0.00003945416,0.003856797,0.0001968432],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.989791,0.005462114,0.000005297355,0.003526707,0.0001690603,0.0005949126,0.00001712922,0.0000313998,0.0004024215],"genre_scores_gemma":[0.9790521,0.01849785,0.0001720831,0.0003344239,0.0006028347,0.000101798,0.000009200273,0.00004078937,0.00118896],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05941922,"threshold_uncertainty_score":0.9681837,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2377519314150681,"score_gpt":0.5075417239301775,"score_spread":0.2697897925151094,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}